C-Ray Therapeutics
PrivateLast Round
Series A
Extension
Nov 16, 2024
Total Funding Raised
$100M
Company Overview
C-Ray Therapeutics is a biopharmaceutical company that provides end-to-end radiopharmaceutical development and manufacturing services, including preclinical evaluation, clinical supply, and commercial-scale cGMP production.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
C-Ray Therapeutics Comparables
Compare C-Ray Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AlphaGen Therapeutics | 92% | |
| Bivision Pharma | 87% | |
| Full-Life Technologies | 84% | |
C-Ray Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Nov 16, 2024 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 16, 2024
$100M round with participation from 3SBio Inc.
C-Ray Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about C-Ray Therapeutics's valuation, stock price, and market status.